XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of cash and cash equivalents
Cash, cash equivalents and restricted cash consist of the following:
September 30,
2022
December 31,
2021
Cash and cash equivalents$231,805 $278,933 
Restricted cash1,578 927 
Total cash, cash equivalents and restricted cash$233,383 $279,860 
Restrictions on cash and cash equivalents
Cash, cash equivalents and restricted cash consist of the following:
September 30,
2022
December 31,
2021
Cash and cash equivalents$231,805 $278,933 
Restricted cash1,578 927 
Total cash, cash equivalents and restricted cash$233,383 $279,860 
Schedule of securities and other investments owned and securities sold not yet purchased at fair value
As of September 30, 2022 and December 31, 2021, the Company’s securities and other investments owned and securities sold not yet purchased at fair value consisted of the following securities:
September 30,
2022
December 31,
2021
Securities and other investments owned:
Equity securities$1,140,728 $1,444,474 
Corporate bonds6,761 7,632 
Other fixed income securities8,649 2,606 
Partnership interests and other82,475 77,383 
$1,238,613 $1,532,095 
Securities sold not yet purchased:
Equity securities$10,801 $20,302 
Corporate bonds6,264 6,327 
Other fixed income securities686 1,994 
$17,751 $28,623 
Schedule of financial assets and liabilities measured on recurring basis
The following tables present information on the financial assets and liabilities measured and recorded at fair value on a recurring basis as of September 30, 2022 and December 31, 2021.
Financial Assets and Liabilities Measured at Fair Value on a
Recurring Basis as of September 30, 2022 Using
Fair value as of September 30, 2022
Quoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
Assets:
Funds held in trust account$173,216 $173,216 $— $— 
Securities and other investments owned:    
Equity securities1,056,448 717,092 — 339,356 
Corporate bonds6,761 — 6,761 — 
Other fixed income securities8,649 — 8,649 — 
Total securities and other investments owned1,071,858 717,092 15,410 339,356 
Loans receivable, at fair value814,715 — — 814,715 
Total assets measured at fair value$2,059,789 $890,308 $15,410 $1,154,071 
Liabilities:
Securities sold not yet purchased:
Equity securities$10,801 $10,801 $— $— 
Corporate bonds6,264 — 6,264 — 
Other fixed income securities686 — 686 — 
Total securities sold not yet purchased17,751 10,801 6,950 — 
Mandatorily redeemable noncontrolling interests issued after November 5, 20034,322 — — 4,322 
Warrant liabilities633 633 — — 
Contingent consideration29,578 — — 29,578 
Total liabilities measured at fair value$52,284 $11,434 $6,950 $33,900 
Financial Assets and Liabilities Measured at Fair Value on a
Recurring Basis at December 31, 2021 Using
Fair value at December 31, 2021
Quoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
Assets:
Funds held in trust account$345,024 $345,024 $— $— 
Securities and other investments owned:
Equity securities1,384,729 1,007,180 — 377,549 
Corporate bonds7,632 — 7,632 — 
Other fixed income securities2,606 — 2,606 — 
Total securities and other investments owned1,394,967 1,007,180 10,238 377,549 
Loans receivable, at fair value873,186 — — 873,186 
Total assets measured at fair value$2,613,177 $1,352,204 $10,238 $1,250,735 
    
Liabilities:    
Securities sold not yet purchased:    
Equity securities$20,302 $20,302 $— $— 
Corporate bonds6,327 — 6,327 — 
Other fixed income securities1,994 — 1,994 — 
Total securities sold not yet purchased28,623 20,302 8,321 — 
Mandatorily redeemable noncontrolling interests issued after November 5, 20034,506 — — 4,506 
Warrant liabilities12,938 12,938 — — 
Total liabilities measured at fair value$46,067 $33,240 $8,321 $4,506 
Schedule of fair value measurement inputs and valuation techniques The following table summarizes the significant unobservable inputs in the fair value measurement of Level 3 financial assets and liabilities by category of investment and valuation technique as of September 30, 2022:
Fair value at
September 30, 2022
Valuation
Technique
Unobservable
Input
RangeWeighted
Average
Assets:
Equity securities$267,745 Market approachMultiple of EBITDA
1.80x - 13.00x
6.49x
Multiple of Sales
1.00x
1.00x
Market price of related security
$10.03 - $16.81
$13.72
65,044 Discounted cash flowMarket interest rate17.8%17.8%
6,567 Option pricing modelAnnualized volatility
30.0% - 200.0%
57.4%
Loans receivable at fair value814,715 Discounted cash flow/Market approachMarket interest rate/Market price of related security
6.0% - 33.5%
21.9%
Total level 3 assets measured at fair value$1,154,071 
Liabilities:
Mandatorily redeemable noncontrolling interests issued after November 5, 2003$4,322 Market approachOperating income multiple6.0x6.0x
Contingent consideration29,578 Discounted cash flowEBITDA volatility65.0%65.0%
Market interest rate8.5%8.5%
Total level 3 liabilities measured at fair value$33,900 
Schedule of fair value measurement of level 3 financial assets and liabilities
The changes in Level 3 fair value hierarchy during the nine months ended September 30, 2022 and 2021 were as follows:
Level 3
Balance at
Beginning of
Year
Level 3 Changes During the Period Level 3
Balance at
End of
Period
Fair
Value
Adjustments
Relating to
Undistributed
Earnings
Purchases,
Sales and
Settlements
Transfer in
and/or out
of Level 3
Nine Months Ended September 30, 2022
Equity securities$377,549 $(18,594)$— $18,457 $(38,056)$339,356 
Loans receivable at fair value873,186 (19,205)9,554 (7,983)(40,837)814,715 
Mandatorily redeemable noncontrolling interests issued after November 5, 2003 4,506 — 824 (1,008)— 4,322 
Contingent consideration— (3,880)— 33,458 — 29,578 
Nine Months Ended September 30, 2021
Equity securities $149,292 $52,102 $— $125,794 $5,777 $332,965 
Loans receivable at fair value390,689 9,059 9,003 (57,989)— 350,762 
Mandatorily redeemable noncontrolling interests issued after November 5, 2003 4,700 — (504)— — 4,196 
Warrant liabilities— — — 10,466 (10,466)— 
Schedule of financial assets measured on nonrecurring basis
The following table presents information on the assets measured at fair value on a nonrecurring basis by level within the fair value hierarchy as of September 30, 2022. These investments were measured due to an observable price change or impairment during the nine months ended September 30, 2022.
Fair Value Measurement Using
TotalQuoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
As of September 30, 2022
  
Investments in nonpublic entities that do not report NAV$16,387 $— $15,737 $650 
Redeemable Noncontrolling Interest
Changes to redeemable noncontrolling interest consist of the following:
Nine Months Ended September 30, 2022
Balance, January 1, 2022$345,000 
Net loss(1,078)
De-consolidation of BRPM 150 (172,584)
Contributions8,021 
Distributions(600)
Balance, September 30, 2022$178,759 
Schedule of investments in the VIE
The carrying value of the Company’s investments in the VIEs that were not consolidated is shown below.
September 30,
2022
December 31,
2021
Securities and other investments owned, at fair value$35,291 $27,445 
Loans receivable, at fair value70,400 205,265 
Other assets3,129 4,956 
Maximum exposure to loss$108,820 $237,666